← Back to Search
Unsafe And Potentially Safe Herbal Therapies.
T. B. Klepser, M. Klepser
Published 1999 · Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Unsafe and potentially safe herbal therapies are discussed. The use of herbal therapies is on the rise in the United States, but most pharmacists are not adequately prepared educationally to meet patients' requests for information on herbal products. Pharmacists must also cope with an environment in which there is relatively little regulation of herbal therapies by FDA. Many herbs have been identified as unsafe, including borage, calamus, coltsfoot, comfrey, life root, sassafras, chaparral, germander, licorice, and ma huang. Potentially safe herbs include feverfew, garlic, ginkgo, Asian ginseng, saw palmetto, St. John's wort, and valerian. Clinical trials have been used to evaluate feverfew for migraine prevention and rheumatoid arthritis; garlic for hypertension, hyperlipidemia, and infections; ginkgo for circulatory disturbances and dementia; ginseng for fatigue and cancer prevention; and saw palmetto for benign prostatic hyperplasia. Also studied in formal trials have been St. John's wort for depression and valerian for insomnia. The clinical trial results are suggestive of efficacy of some herbal therapies for some conditions. German Commission E, a regulatory body that evaluates the safety and efficacy of herbs on the basis of clinical trials, cases, and other scientific literature, has established indications and dosage recommendations for many herbal therapies. Pharmacists have a responsibility to educate themselves about herbal therapies in order to help patients discern the facts from the fiction, avoid harm, and gain what benefits may be available.
This paper references
Ginseng abuse syndrome. Problems with the panacea.
R. K. Siegel (1979)
Ginseng and high blood pressure.
R. K. Siegel (1980)
Oestrogen-like effect of ginseng.
R. Punnonen (1980)
PLATELET AGGREGATION INHIBITOR IN GARLIC
T. Ariga (1981)
Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man
P. Leathwood (1982)
A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).
Makheja An (1982)
Ginseng and vaginal bleeding.
E. Greenspan (1983)
A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.
G. Champault (1984)
6-Month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency.
U. Bauer (1984)
Inhibition of Monoamine Oxidase by Hypercin
O. Suzuki (1984)
Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
E. Carilla (1984)
Efficacy of feverfew as prophylactic treatment of migraine.
E. Johnson (1985)
Aqueous extract of valerian reduces latency to fall asleep in man.
P. Leathwood (1985)
EXTRACTS OF FEVERFEW INHIBIT GRANULE SECRETION IN BLOOD PLATELETS AND POLYMORPHONUCLEAR LEUCOCYTES
S. Heptinstall (1985)
Phenelzine and the dream machine--ramblings and reflections.
R. Shader (1985)
The value of permixon in benign prostatic hypertrophy.
H. Reece Smith (1986)
A double-blind, placebo-controlled clinical study on the effect of a standardized ginseng extract on psychomotor performance in healthy volunteers.
L. D'Angelo (1986)
Interaction of ginseng with phenelzine.
B. D. Jones (1987)
The activity of compounds extracted from feverfew on histamine release from rat mast cells
N. Hayes (1987)
A double‐blind placebo‐controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly
K. Wesnes (1987)
Effect of an odor-modified garlic preparation on blood lipids
B. Lau (1987)
Ginseng--is there a use in clinical medicine?
S. Chong (1988)
Effects of spray dried garlic preparation on primary hyperlipoproteinemia.
C. Plengvidhya (1988)
The biological activity of Valerian and related plants.
P. Houghton (1988)
VALERIAN: A LITERATURE REVIEW
C. Hobbs (1989)
Feverfew in rheumatoid arthritis: a double blind, placebo controlled study.
M. Pattrick (1989)
[Efficacy of an extract of Ginkgo biloba in the treatment of chronic obliterating arteriopathies of the lower limbs in stage III of Fontaine's classification].
F. Saudreau (1989)
Hypertension and hyperlipidaemia: garlic helps in mild cases.
W. Auer (1990)
Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study.
F. Mader (1990)
Therapy with garlic: results of a placebo-controlled, double-blind study.
G. Vorberg (1990)
Effect of garlic on thrombocyte aggregation, microcirculation, and other risk factors.
H. Kiesewetter (1991)
Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance during exercise.
G. Pieralisi (1991)
PAF. A review of its effects, antagonists and possible future clinical implications (Part II).
M. Koltai (1991)
Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity.
D. Larrey (1992)
Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components.
H. Sumner (1992)
Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate.
H. Holzgartner (1992)
Ginkgo biloba for cerebral insufficiency.
J. Kleijnen (1992)
Can garlic reduce levels of serum lipids? A controlled clinical study.
A. Jain (1993)
Hépatite chronique active et cirrhose induites par la germandrée petit-chêne : trois cas
M. Yahia (1993)
Unconventional medicine in the United States. Prevalence, costs, and patterns of use.
D. Eisenberg (1993)
Effect of Garlic on Total Serum Cholesterol
S. Warshafsky (1993)
Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess.
B. Walker (1994)
Tyler’s Herbs of Choice: The Therapeutic Use of Phytomedicinals
V. Tyler (1994)
Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy.
S. Alderman (1994)
Evaluation of the Ergogenic Properties of Ginseng
M. Bahrke (1994)
A meta‐analysis of the effect of garlic on blood pressure
C. Silagy (1994)
Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients.
H. Woelk (1994)
Ginseng Therapy in Non-Insulin-Dependent Diabetic Patients: Effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight
E. Sotaniemi (1995)
Placebo-Controlled Evaluation of the Efficacy and Tolerability of Permixon® in Benign Prostatic Hyperplasia after Exclusion of Placebo Responders
J. Descotes (1995)
Allium sativum and Allium ursinum: Part 2 pharmacology and medicinal application.
H. D. Reuter (1995)
St John's wort for depression—an overview and meta-analysis of randomised clinical trials
K. Linde (1996)
Serenoa repens (Permixon®)
G. Plosker (1996)
Comparison of phytotherapy (Permixon®) with finasteride in the treatment of benign prostate hyperplasia: A randomized international study of 1,098 patients
Jean‐Christophe Carraro (1996)
What pharmacists should know about herbal remedies.
V. Tyler (1996)
Herbal medicines in migraine prevention Randomized double-blind placebo-controlled crossover trial of a feverfew preparation.
C. J. de Weerdt (1996)
Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion
J. Rowin (1996)
The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
H. Lepor (1996)
Herbal products begin to attract the attention of brand-name drug companies.
K. Cottrell (1996)
Spontaneous hyphema associated with ingestion of Ginkgo biloba extract.
M. Rosenblatt (1997)
A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia
P. L. Bars (1997)
Probable interaction between warfarin and ginseng.
K. Janetzky (1997)
Serotonin syndrome. A clinical update.
K. C. Mills (1997)
Herbal Instruction in United States Pharmacy Schools
L. Miller (1997)
Efficacy and tolerability of finasteride in symptomatic benign prostatic hyperplasia: a primary care study
J. Tenover (1997)
Feverfew (Tanacetum parthenium) as a prophylactic treatment for migraine: a double‐blind placebo‐controlled study
D. Palevitch (1997)
This paper is referenced by
Two Cases of Toxic Keratoconjunctivitis due to Ginkgo Nut Contact
Joo Sang Oh (2021)
Role of Oral Supplements: When and How to Choose
Hind Almohanna (2020)
Hair and Scalp Treatments: A Practical Guide
Antonella Tosti (2020)
Clopidogrel drug interactions: a review of the evidence and clinical implications
Chang Hoon Lee (2020)
Gyógynövények használata elektív műtéti beavatkozás előtt. Kérdőíves felmérés egy egyetemi klinika és egy városi kórház betegei körében
S. Soós (2020)
Herbal medicines: a cross-sectional study to evaluate the prevalence and predictors of use among Jordanian adults
F. El-Dahiyat (2020)
Constructing a bilingual website with validated database for Herb and Western medicine interactions using Ginseng, Ginkgo and Dong Quai as examples
Chang-Shiann Wu (2019)
Development of a Food Supplement for Diabetes Type II Management With Enhanced Antidiabetic and Antioxidant Properties From Selected Local Foods
Y. Hengame (2019)
Why people use herbal medicine: insights from a focus-group study in Germany
Alexandra N. Welz (2018)
Use of industrialized herbal medicines by patients attended at the basic health units in the County of Pinhais, Paraná, Brazil
Caroline Gribner (2018)
M. Glenn (2018)
Melia Azedarach L. Fruit Extract Effect on Plasma Lipid Profile and Cardiac and Hepatic Functions of Diabetic Rats
Omid Afkhami-Ardekani (2017)
Teratogenicity and Developmental Toxicity of Herbal Products
E. Seo (2017)
PHYTOCHEMICAL, PHARMACOLOGICAL AND BIOLOGICAL PROFILES OF TRAGIA SPECIES (FAMILY: EUPHORBIACEAE)
B. S. Reddy (2017)
THE EFFECT OF GINKGO FORMULATIONS ON PLATELET AGGREGATION IN RATS
M. Skoko (2017)
Psoriasis and the liver: problems, causes and course
Elona Tula (2017)
Integrated Approach to Arrhythmias
Carlo Dal Lin (2017)
Gintonin facilitates catecholamine secretion from the perfused adrenal medulla
Seung-Yeol Na (2016)
Evaluation of Inorganic Elements in Herbal preparation by FAAS and FES
M. T. Ansari (2016)
The effect of Zataria multiflora extract on the clinical endometritis and reproductive indices in lactating Holstein dairy cows
A. Hajibemani (2016)
What do we know about phytotherapy of benign prostatic hyperplasia?
Olta Allkanjari (2015)
Cross matching observations on toxicological and clinical data for the assessment of tolerability and safety of Ginkgo biloba leaf extract.
T. Heinonen (2015)
Modulatory actions of o-coumaric acid on carcinogen-activating cytochrome P450 isozymes and the potential for drug interactions in human hepatocarcinoma cells*
A. Şen (2015)
The combination of “Pimpinella anisum, Apium graveolens and Crocus sativus (PAC)” is more effective than “mefenamic acid” on postpartum after-pain
M. Simbar (2015)
Methodology for the Development of Evidence-based Herbal Tonics for Preventive Purposes
Leung Ping-chung (2015)
In Search of a Safe Natural Sleep Aid
T. Rao (2015)
THE EFFECT OF AQUEOUS EXTRACT OF GARLIC ON FORMALIN-INDUCED PAIN IN MALE RATS.
N. Roozbahani (2014)
The effect of Ginkgo biloba extracts on the pharmacokinetics and pharmacodynamics of cilostazol and its active metabolites in healthy Korean subjects.
H. Kim (2014)
Anticandidal effects of aqueous and callus extracts of Artemisia aucheri
Mansoureh Roofigari Isfahan (2014)
Cancer Patients at Risk of Herb/Food Supplement–Drug Interactions: A Systematic Review
Saud M. Alsanad (2014)
Molecular and Clinical Microbiology
Mansoureh Roofigari Isfahan (2014)
A STUDY OF SUBACUTE TOXICITY OF KAJJALI, A COMBINATION OF MERCURY AND SULPHUR ON ALBINO RATS
Therasilin Louis (2014)See more